浙大醫(yī)學(xué)院腫瘤生物治療教授滕理送個人信息

主持的主要課題（包括完成項(xiàng)目)：
1.國家973項(xiàng)目子課題：《器官移植術(shù)后腫瘤復(fù)發(fā)的免疫學(xué)分子機(jī)理及干預(yù)策略研究》
國家863重大項(xiàng)目子課題：《腫瘤抗體藥物》
國家973項(xiàng)目子課題：《腫瘤細(xì)胞周期捕獲與血管生成的分子基礎(chǔ)研究》
2.國家自然基金：《新型雌激素受體亞型ER-α36在人乳腺癌中的表達(dá)和作用研究》,《新型免疫增強(qiáng)型腫瘤裂解病毒的研制》
《恢復(fù)人端粒酶活性與建立正常人源肝細(xì)胞株研究》
3.省部級課題： 《仿真人體的胃癌裸鼠移植,模型的建立及其臨床應(yīng)用研究》（科技廳重大)
《滕理送、蔡真、曹江人才項(xiàng)目》（省自然人才)等多項(xiàng)
4.省中醫(yī)藥中西醫(yī)結(jié)合腫瘤治療學(xué)重點(diǎn)學(xué)科建設(shè)資助（一期、二期)。

近年發(fā)表的主要論文：
1.Wang WB, Wang HY, Teng XD, Wang HH, Mao CY, Teng RY, Zhao WH, Cao J, Thomas J. Fahey III, Teng LS. Clonal analysis of bilateral, recurrent and metastatic papillary thyroid carcinomas. Human Pathology，2010，Accepted .
2.Zheng Y, Zhang J, Xu ZZ, Sheng JM, Zhang XC, Wang HH, Teng XD, Liu XJ, Cao J, Teng LS. Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues. J Zhejiang Univ Sci B. 2010 Feb;11(2):144-50.gydjdsj.org.cn
3.Wang H, Zhang X, Geng L, Teng L, Legerski RJ. Artemis regulates cell cycle recovery from the S phase checkpoint by promoting degradation of cyclin E. J Biol Chem. 2009 Jul 3;284(27):18236-43.
4.Mao CY, Hua HJ, Chen P, Yu DC, Cao J, Teng LS. Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):282-7.
5.Teng LS, Zheng Y, Wang HH. BRCA1/2 associated hereditary breast cancer. J Zhejiang Univ Sci B. 2008 Feb;9(2):85-9.
6.Jiang HP, Teng RY, Wang Q, Zhang X, Wang HH, Cao J, Teng LS. Estrogen receptor alpha variant ERalpha46 mediates growth inhibition and apoptosis of human HT-29 colon adenocarcinoma cells in the presence of 17beta-oestradiol. Chin Med J (Engl). 2008 Jun 5;121(11):1025-31.
7.Jiang HP, Teng RY, Wang Q, Zhang X, Wang HH, Cao J, Teng LS. Estrogen receptor alpha variant ERalpha46 mediates growth inhibition and apoptosis of human HT-29 colon adenocarcinoma cells in the presence of 17beta-oestradiol. Chin Med J (Engl). 2008;121(11):1025-31.
8.Jiang H, Teng R, Wang Q, Zhang X, Wang H, Wang Z, Cao J, Teng L. Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues. J Steroid Biochem Mol Biol. 2008;112(1-3):20-4.gydjdsj.org.cn
9.Teng L, Specht MC, Barden CB, Fahey TJ 3rd. Antisense hTERT inhibits thyroid cancer cell growth. J Clin Endocrinol Metab.2003; 88(3):1362-6.
10.Specht MC, Tucker ON, Hocever M, Gonzalez D, Lisong Teng, et al. Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab. 2002; 87(1):358-63

上一頁  [1] [2] [3]  下一頁